经动脉化疗治疗肝转移瘤。
Intraarterial Chemotherapy for Liver Metastases.
机构信息
Department of Medicine, Gastrointestinal Oncology Service, Memorial Sloan Kettering Cancer Center, 300 East 66th Street, 10th floor, New York, NY 10065, USA.
Department of Medicine, Gastrointestinal Oncology Service, Memorial Sloan Kettering Cancer Center, 300 East 66th Street, 10th floor, New York, NY 10065, USA.
出版信息
Surg Oncol Clin N Am. 2021 Jan;30(1):143-158. doi: 10.1016/j.soc.2020.08.005. Epub 2020 Oct 20.
Abstract
Colorectal cancer (CRC) is one of the leading cancers globally in terms of both incidence and cancer-related mortality. Liver metastatic disease is the main prognostic driver for patients with CRC. The management options for liver metastatic CRC continue to evolve, particularly with the incorporation of locoregional therapies into the treatment paradigm. Hepatic arterial infusion (HAI) chemotherapy is one such liver directed approach used with the goal of converting patients to liver resection, reducing the risk of recurrence, treating recurrent disease, and most importantly improving overall survival. This article summarizes the role of HAI chemotherapy in the treatment of liver metastatic CRC.
摘要
结直肠癌（CRC）在发病率和癌症相关死亡率方面均是全球主要癌症之一。肝转移疾病是 CRC 患者的主要预后驱动因素。肝转移性 CRC 的治疗选择在不断发展，特别是将局部区域治疗纳入治疗模式。肝动脉灌注（HAI）化疗就是一种肝脏定向治疗方法，目的是使患者能够进行肝切除术，降低复发风险，治疗复发性疾病，最重要的是提高总体生存率。本文总结了 HAI 化疗在治疗肝转移性 CRC 中的作用。
相似文献
1
Intraarterial Chemotherapy for Liver Metastases.经动脉化疗治疗肝转移瘤。
Surg Oncol Clin N Am. 2021 Jan;30(1):143-158. doi: 10.1016/j.soc.2020.08.005. Epub 2020 Oct 20.
2
Conversion to resection of liver metastases from colorectal cancer with hepatic artery infusion of combined chemotherapy and systemic cetuximab in multicenter trial OPTILIV.多中心试验 OPTILIV 中，肝动脉灌注联合化疗和全身西妥昔单抗治疗结直肠癌肝转移转化为切除术。
Ann Oncol. 2016 Feb;27(2):267-74. doi: 10.1093/annonc/mdv548. Epub 2015 Nov 16.
3
Genomic Predictors of Recurrence Patterns After Complete Resection of Colorectal Liver Metastases and Adjuvant Hepatic Artery Infusion Chemotherapy by Narayan et al.纳拉扬等人所著的《结直肠癌肝转移灶完全切除及辅助肝动脉灌注化疗后复发模式的基因组预测指标》
Ann Surg Oncol. 2022 Nov;29(12):7246-7247. doi: 10.1245/s10434-022-12198-5. Epub 2022 Jul 12.
4
A randomized phase III study of hepatic arterial infusion chemotherapy with 5-fluorouracil and subsequent systemic chemotherapy versus systemic chemotherapy alone for colorectal cancer patients with curatively resected liver metastases (Japanese Foundation for Multidisciplinary Treatment of Cancer 32).一项针对已接受根治性切除肝转移灶的结直肠癌患者，比较氟尿嘧啶肝动脉灌注化疗及后续全身化疗与单纯全身化疗的随机III期研究（日本多学科癌症治疗基金会32）
J Cancer Res Ther. 2018 Sep;14(Supplement):S761-S766. doi: 10.4103/0973-1482.179188.
5
Randomized phase II study of 5-fluorouracil hepatic arterial infusion with or without antineoplastons as an adjuvant therapy after hepatectomy for liver metastases from colorectal cancer.5-氟尿嘧啶肝动脉灌注联合或不联合抗肿瘤药作为结直肠癌肝转移肝切除术后辅助治疗的随机II期研究
PLoS One. 2015 Mar 19;10(3):e0120064. doi: 10.1371/journal.pone.0120064. eCollection 2015.
6
7
8
Randomized trial of surgery versus surgery followed by adjuvant hepatic arterial infusion with 5-fluorouracil and folinic acid for liver metastases of colorectal cancer. German Cooperative on Liver Metastases (Arbeitsgruppe Lebermetastasen).手术与手术后辅助肝动脉灌注5-氟尿嘧啶和亚叶酸治疗结直肠癌肝转移的随机试验。德国肝转移协作组（ Arbeitsgruppe Lebermetastasen ）
Ann Surg. 1998 Dec;228(6):756-62. doi: 10.1097/00000658-199812000-00006.
9
Adjuvant chemotherapy after resection of colorectal liver metastases in patients at high risk of hepatic recurrence: a comparative study between hepatic arterial infusion of oxaliplatin and modern systemic chemotherapy.结直肠肝转移术后高危肝复发患者的辅助化疗：奥沙利铂肝动脉灌注与现代全身化疗的对比研究。
Ann Surg. 2013 Jan;257(1):114-20. doi: 10.1097/SLA.0b013e31827b9005.
10
[A study of regional chemotherapy: hepatic arterial infusion for metastatic liver tumors].[区域化疗研究：肝动脉灌注治疗转移性肝肿瘤]
Gan To Kagaku Ryoho. 1994 Sep;21(13):2155-7.
引用本文的文献
1
Case Report WIN-MTB-2023001 WIN International Molecular Tumor Board A 62-year-old male with metastatic colorectal cancer with 5 prior lines of treatment.病例报告 WIN-MTB-2023001 WIN国际分子肿瘤委员会 一名62岁男性，患有转移性结直肠癌，此前接受过5线治疗。
Oncotarget. 2025 Jun 17;16:456-466. doi: 10.18632/oncotarget.28744.
2
State-of-the-art in Metastatic Uveal Melanoma Treatment: A 2025 Update : How to treat Metastatic Uveal Melanoma in 2025.转移性葡萄膜黑色素瘤治疗的最新进展：2025年更新版：如何在2025年治疗转移性葡萄膜黑色素瘤。
Curr Oncol Rep. 2025 May 17. doi: 10.1007/s11912-025-01684-0.
3
Progression of oncolytic virus in liver cancer treatment.溶瘤病毒在肝癌治疗中的进展。
Front Oncol. 2024 Sep 26;14:1446085. doi: 10.3389/fonc.2024.1446085. eCollection 2024.
本文引用的文献
1
Colorectal cancer statistics, 2020.2020 年结直肠癌统计数据。
CA Cancer J Clin. 2020 May;70(3):145-164. doi: 10.3322/caac.21601. Epub 2020 Mar 5.
2
Role of Hepatic Artery Infusion Chemotherapy in Treatment of Initially Unresectable Colorectal Liver Metastases: A Review.肝动脉灌注化疗在不可切除结直肠癌肝转移治疗中的作用：综述。
JAMA Surg. 2019 Aug 1;154(8):768-776. doi: 10.1001/jamasurg.2019.1694.
3
Adjuvant hepatic arterial infusion pump chemotherapy and resection versus resection alone in patients with low-risk resectable colorectal liver metastases - the multicenter randomized controlled PUMP trial.低危可切除结直肠癌肝转移患者中辅助性肝动脉灌注泵化疗联合切除术与单纯切除术的比较——多中心随机对照 PUMP 试验。
BMC Cancer. 2019 Apr 5;19(1):327. doi: 10.1186/s12885-019-5515-6.
4
Postoperative hepatic arterial chemotherapy in high-risk patients as adjuvant treatment after resection of colorectal liver metastases - a randomized phase II/III trial - PACHA-01 (NCT02494973).结直肠肝转移切除术后高危患者辅助治疗的术后肝动脉化疗-一项随机 II/III 期试验-PACHA-01（NCT02494973）。
BMC Cancer. 2018 Aug 6;18(1):787. doi: 10.1186/s12885-018-4697-7.
5
Prospective phase II trial of combination hepatic artery infusion and systemic chemotherapy for unresectable colorectal liver metastases: Long term results and curative potential.肝动脉灌注联合全身化疗治疗不可切除结直肠癌肝转移的前瞻性II期试验：长期结果及治愈潜力
J Surg Oncol. 2018 Mar;117(4):634-643. doi: 10.1002/jso.24898. Epub 2017 Nov 22.
6
Hepatic Arterial Infusion Chemotherapy for Unresectable Liver Metastases of Colorectal Cancer: A Multicenter Retrospective Study.结直肠癌不可切除肝转移的肝动脉灌注化疗：一项多中心回顾性研究。
Clin Colorectal Cancer. 2017 Dec;16(4):308-315. doi: 10.1016/j.clcc.2017.03.003. Epub 2017 Mar 14.
7
Perioperative Hepatic Arterial Infusion Pump Chemotherapy Is Associated With Longer Survival After Resection of Colorectal Liver Metastases: A Propensity Score Analysis.围手术期肝动脉灌注泵化疗与结直肠癌肝转移切除术后更长生存期相关：一项倾向评分分析。
J Clin Oncol. 2017 Jun 10;35(17):1938-1944. doi: 10.1200/JCO.2016.71.8346. Epub 2017 Apr 20.
8
Robotic hepatic arterial infusion pump placement.机器人辅助肝动脉灌注泵置入术。
HPB (Oxford). 2017 May;19(5):429-435. doi: 10.1016/j.hpb.2016.12.015. Epub 2017 Jan 26.
9
Relevance of CEA and LDH in relation to KRAS status in patients with unresectable colorectal liver metastases.癌胚抗原（CEA）和乳酸脱氢酶（LDH）与不可切除的结直肠癌肝转移患者KRAS状态的相关性
J Surg Oncol. 2017 Mar;115(4):480-487. doi: 10.1002/jso.24536. Epub 2016 Dec 23.
10
Response rates of hepatic arterial infusion pump therapy in patients with metastatic colorectal cancer liver metastases refractory to all standard chemotherapies.肝动脉灌注泵疗法对所有标准化疗均耐药的转移性结直肠癌肝转移患者的缓解率。
J Surg Oncol. 2016 Nov;114(6):655-663. doi: 10.1002/jso.24399. Epub 2016 Aug 26.
Zotero 插件